Profile
Full Name
Quince Therapeutics, Inc.Ticker Symbol
QNCXExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
May 9, 2019Indexes
Not includedWebsite
http://www.quincetx.comEmployees
36Key Details
Price
$0.99(-0.90%)
Market cap
$43.61M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$1.31(-55.95% YoY)
PE ratio
-
Next earnings date
May 13, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Quince Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 25, 25 D. Boral Capital
BuyMar 24, 25 Oppenheimer
OutperformFeb 5, 25 D. Boral Capital
BuyJan 2, 25 D. Boral Capital
BuyDec 18, 24 Brookline Capital
BuyNov 14, 24 D. Boral Capital
BuyNov 12, 24 D. Boral Capital
BuyNov 7, 24 Maxim Group
BuyOct 29, 24 Rodman & Renshaw
BuyOct 22, 24 EF Hutton
BuyInstitutional Ownership
- What is the ticker symbol for Quince Therapeutics?
- Does Quince Therapeutics pay dividends?
- What sector is Quince Therapeutics in?
- What industry is Quince Therapeutics in?
- What country is Quince Therapeutics based in?
- When did Quince Therapeutics go public?
- Is Quince Therapeutics in the S&P 500?
- Is Quince Therapeutics in the NASDAQ 100?
- Is Quince Therapeutics in the Dow Jones?
- When was Quince Therapeutics's last earnings report?
- When does Quince Therapeutics report earnings?
- Should I buy Quince Therapeutics stock now?
What is the ticker symbol for Quince Therapeutics?
The ticker symbol for Quince Therapeutics is NASDAQ:QNCX
Does Quince Therapeutics pay dividends?
No, Quince Therapeutics does not pay dividends
What sector is Quince Therapeutics in?
Quince Therapeutics is in the Healthcare sector
What industry is Quince Therapeutics in?
Quince Therapeutics is in the Biotechnology industry
What country is Quince Therapeutics based in?
Quince Therapeutics is headquartered in United States
When did Quince Therapeutics go public?
Quince Therapeutics's initial public offering (IPO) was on May 9, 2019
Is Quince Therapeutics in the S&P 500?
No, Quince Therapeutics is not included in the S&P 500 index
Is Quince Therapeutics in the NASDAQ 100?
No, Quince Therapeutics is not included in the NASDAQ 100 index
Is Quince Therapeutics in the Dow Jones?
No, Quince Therapeutics is not included in the Dow Jones index
When was Quince Therapeutics's last earnings report?
Quince Therapeutics's most recent earnings report was on Mar 24, 2025
When does Quince Therapeutics report earnings?
The next expected earnings date for Quince Therapeutics is May 13, 2025
Should I buy Quince Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions